BUSINESS

• Shonan Health Innovation Park Marks Grand Opening: Takeda
  April 16, 2018

• Oncodesign Partners with Erytech to Support Preclinical Development of Anticancer Drugs
  April 16, 2018

• Mylan Gets EU Rights for Fujifilm Kyowa Kirin Biologics’ Humira Biosimilar
  April 12, 2018

• Chugai Drops Patent Suit over Nippon Kayaku’s Herceptin Biosimilar
  April 12, 2018

• Japan Ethical Drug Sales Total 9.9 Trillion Yen in FY2017: Encise Snapshot
  April 11, 2018

• Mitsubishi Tanabe’s ALS Drug Filing Accepted for Review in Canada
  April 11, 2018

• Takeda Carve-Out Venture Boots Up with 250 Million Yen Seed Round
  April 11, 2018

• Hisamitsu’s Japan Ethical Drug Sales Down 3.1% in FY2017
  April 11, 2018

• Mitsubishi Tanabe Files with International Court for Upfront Payment Return from S. Korean Firm
  April 11, 2018

• Osaka Univ. Spinout, Sumitomo Dainippon Strike Option Deal on Antibody-Inducing Peptides
  April 10, 2018

• Otsuka Partners with Takara Bio to Codevelop Gene Therapy Products with Exclusive Sales Rights in Japan
  April 10, 2018

• Ethical Drug Sales Up 1.0% in February: Crecon Report
  April 9, 2018

• Kowa Gets High Court Backing in Livalo Patent Suit
  April 9, 2018

• Alfresa to Fully Introduce Distribution Cost Analysis System; Will “Raise Reps’ Awareness of Importance of Price Negotiations”: Pres.
  April 9, 2018

• Japan Generic Market Projected at 1.2 Trillion Yen in 2021: Fuji Keizai
  April 6, 2018

• Takeda, DNDi to Collaborate in Visceral Leishmaniasis Drug Development
  April 6, 2018

• Daiichi Sankyo Expands Cancer Collaboration with DarwinHealth
  April 6, 2018

• Takeda to Divest Its Brazilian OTC, Gx Subsidiary to Local Pharma
  April 6, 2018

• Zyprexa Generics Now Carry Same Indications as Originator
  April 5, 2018

• Nebulized COPD Med Lonhala Magnair Now Available in US: Sunovion
  April 5, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 400
• 401
• 402
• 403
• 404
• 405
• 406
• 407
• 408
• …
• Next ›
• 最終 »